Quitline Queensland: the journey to a globally unique smoking cessation service in Australia
Smoking cessation programs remain a core component of global efforts to reduce smoking and nicotine addiction. Telephone-based counselling, with or without the provision of nicotine replacement therapy, commonly referred to as Quitlines, has been a ...
Joanne Isbel +4 more
doaj +1 more source
Successful Cessation Programs that Reduce Comorbidity May Explain Surprisingly Low Smoking Rates Among Hospitalized COVID-19 Patients [PDF]
A recent, non-peer-reviewed meta-analysis suggests that smoking may reduce the risk of hospitalization with COVID-19 because the prevalence of smoking among hospitalized COVID-19 is less than that of the general population.
Alvarez, R. Michael +7 more
core
Evaluating level of adherence to nicotine replacement therapy and its impact on smoking cessation: a protocol for systematic review and meta-analysis [PDF]
Amanual Getnet Mersha +4 more
openalex +1 more source
Second Roundtable Meeting: Innovations in Building Consumer Demand for Tobacco-Cessation Products and Services [PDF]
Outlines February 2007 discussions at the National Tobacco Cessation Collaborative's Consumer Demand Roundtable on supporting the quitting process, building demand for products and services among employers and health plans, and design ...
core
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown +7 more
wiley +1 more source
E-cigarettes for the management of nicotine addiction
Oliver Knight-West, Christopher Bullen The National Institute for Health Innovation, School of Population Health, The University of Auckland, Auckland, New Zealand Abstract: In this review, we discuss current evidence on electronic cigarettes (ECs),
Knight-West O, Bullen C
doaj
Multicenter real‐world cohort (n = 327) comparing LVADs: HeartMate 3 (HM3), HeartMate II (HMII), and HeartWare (HVAD). HM3 showed superior long‐term survival versus legacy devices, driven by fewer hemocompatibility‐related adverse events, especially pump thrombosis and ischemic stroke, while major bleeding was similar across devices.
Hamza H. H. Ben Nasir +9 more
wiley +1 more source
Review: nicotine replacement therapy as assisted "reduction-to-stop" reduces smoking and sustains abstinence in smokers [PDF]
Brian A. Primack
openalex +1 more source
Addressing complexity in the study of life sciences through Systems Biology and Systems Medicine has been transformative, making Systems Pharmacology the next logical step. In this review, we focus on physical stimuli, whose potential in pharmacology has been neglected, despite demonstrated therapeutic properties.
Veronica Paparozzi +10 more
wiley +1 more source
Smoking Cessation, Counseling & Therapy Program Helps Patients Kick the Habit [PDF]
The Department of Surgery’s Smoking Cessation, Counseling & Therapy (SCCT) Program offers evidencebased strategies for quitting smoking, including one-on-one counseling, nicotine replacement therapy and prescription medication, such as Chantix and ...
core +1 more source

